Unknown

Dataset Information

0

Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGF?.


ABSTRACT: High T-cell infiltration in colorectal cancer (CRC) correlates with a favorable disease outcome and immunotherapy response. This, however, is only observed in a small subset of CRC patients. A better understanding of the factors influencing tumor T-cell responses in CRC could inspire novel therapeutic approaches to achieve broader immunotherapy responsiveness. Here, we investigated T cell-suppressive properties of different myeloid cell types in an inducible colon tumor mouse model. The most potent inhibitors of T-cell activity were tumor-infiltrating neutrophils. Gene expression analysis and combined in vitro and in vivo tests indicated that T-cell suppression is mediated by neutrophil-secreted metalloproteinase activation of latent TGF?. CRC patient neutrophils similarly suppressed T cells via TGF? in vitro, and public gene expression datasets suggested that T-cell activity is lowest in CRCs with combined neutrophil infiltration and TGF? activation. Thus, the interaction of neutrophils with a TGF?-rich tumor microenvironment may represent a conserved immunosuppressive mechanism in CRC.

SUBMITTER: Germann M 

PROVIDER: S-EPMC6949488 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Neutrophils suppress tumor-infiltrating T cells in colon cancer via matrix metalloproteinase-mediated activation of TGFβ.

Germann Markus M   Zangger Nadine N   Sauvain Marc-Olivier MO   Sempoux Christine C   Bowler Amber D AD   Wirapati Pratyaksha P   Kandalaft Lana E LE   Delorenzi Mauro M   Tejpar Sabine S   Coukos George G   Radtke Freddy F  

EMBO molecular medicine 20191202 1


High T-cell infiltration in colorectal cancer (CRC) correlates with a favorable disease outcome and immunotherapy response. This, however, is only observed in a small subset of CRC patients. A better understanding of the factors influencing tumor T-cell responses in CRC could inspire novel therapeutic approaches to achieve broader immunotherapy responsiveness. Here, we investigated T cell-suppressive properties of different myeloid cell types in an inducible colon tumor mouse model. The most pot  ...[more]

Similar Datasets

| S-SCDT-EMM-2019-10681 | biostudies-other
| S-EPMC9761036 | biostudies-literature
| S-EPMC8450250 | biostudies-literature
| S-EPMC9654328 | biostudies-literature
| S-EPMC2897379 | biostudies-literature
| S-EPMC2867072 | biostudies-literature
| S-EPMC2745595 | biostudies-literature
| S-EPMC4918202 | biostudies-literature
| S-EPMC1854849 | biostudies-literature
| S-EPMC5465837 | biostudies-literature